Global X Genomics & Biotechnology ETF Rating $9.60 -0.01 (-0.10%) As of 01/17/2025 03:55 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOptions ChainOwnershipRatingsShort InterestTrends Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy 2.68Holdings in GNOM have an aggregate rating of Moderate Buy based on 504 analyst ratings issued in the past year covering 40 companies (97.2% of the portfolio).GNOM Aggregate Price Target$9.60High Prediction$9.60Average Prediction$9.60Low Prediction$9.60Holdings in GNOM have an aggregate price target of $9.60 and a range of $9.60 to $9.60 covering 40 companies (97.2% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 GNOM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.87%NTRANatera$158.36-6.0%2.1961 of 5 stars3.00$160.63 1.4%16Analyst ForecastNews CoverageHigh Trading Volume5.40%VCYTVeracyte$40.58-1.3%3.9993 of 5 stars2.67$41.13 1.3%9Analyst UpgradePositive NewsHigh Trading Volume4.58%QGENQiagen$46.00+0.2%4.184 of 5 stars2.56$51.50 12.0%9Short Interest ↓News Coverage4.51%BNTXBioNTech$111.93-0.7%2.8638 of 5 stars2.88$142.72 27.5%17Short Interest ↑4.47%TECHBio-Techne$75.83-0.4%4.0665 of 5 stars2.63$82.00 8.1%84.35%AAgilent Technologies$147.57+2.0%4.1509 of 5 stars2.43$143.62 -2.7%14Short Interest ↓News CoverageHigh Trading Volume4.28%ARWRArrowhead Pharmaceuticals$19.56+2.8%4.2828 of 5 stars2.60$43.33 121.5%104.14%SRPTSarepta Therapeutics$118.00+0.8%4.9454 of 5 stars2.91$178.71 51.5%22Analyst ForecastAnalyst RevisionNews Coverage4.12%BMRNBioMarin Pharmaceutical$61.53+0.5%4.9993 of 5 stars2.74$94.20 53.1%23Options VolumeNews CoverageHigh Trading Volume3.97%ILMNIllumina$136.67-0.5%4.6418 of 5 stars2.70$165.63 21.2%20Short Interest ↓News Coverage3.90%CRSPCRISPR Therapeutics$40.53+0.6%2.4613 of 5 stars2.47$78.38 93.4%19Analyst ForecastShort Interest ↑News Coverage3.63%BEAMBeam Therapeutics$23.44+0.2%3.6715 of 5 stars2.92$47.67 103.4%123.44%ALNYAlnylam Pharmaceuticals$246.27-1.2%4.4426 of 5 stars2.72$298.61 21.3%25Analyst RevisionNews Coverage3.43%LEGNLegend Biotech$32.66+3.9%2.518 of 5 stars3.00$80.62 146.8%13Short Interest ↓News Coverage3.41%MRNAModerna$34.06+0.9%4.7269 of 5 stars2.13$75.58 121.9%23Analyst ForecastOptions VolumeAnalyst RevisionNews Coverage3.26%RAREUltragenyx Pharmaceutical$40.00-2.1%4.5926 of 5 stars2.93$92.29 130.7%14Analyst RevisionNews Coverage2.98%RNAAvidity Biosciences$28.92+2.2%2.0408 of 5 stars3.00$65.80 127.5%102.90%TXG10x Genomics$15.08-0.1%4.6513 of 5 stars2.53$23.86 58.2%17News CoverageGap Up2.50%NTLAIntellia Therapeutics$9.50+0.8%4.4874 of 5 stars2.72$51.06 437.5%18Analyst ForecastNews Coverage2.42%MYGNMyriad Genetics$12.39-1.0%4.0883 of 5 stars2.00$23.92 93.0%13Analyst ForecastShort Interest ↑News Coverage2.28%GILDGilead Sciences$91.84+0.2%4.3921 of 5 stars2.70$97.96 6.7%27Insider TradeShort Interest ↑Analyst RevisionNews Coverage2.19%RCKTRocket Pharmaceuticals$10.31+1.0%4.5083 of 5 stars2.92$47.27 358.5%12News Coverage2.18%CDNACareDx$21.44-2.8%3.7123 of 5 stars2.57$28.33 32.2%7Analyst ForecastShort Interest ↑Analyst RevisionNews Coverage1.88%VRTXVertex Pharmaceuticals$422.00+1.2%4.2765 of 5 stars2.52$490.38 16.2%311.65%QUREuniQure$14.05-1.1%4.0289 of 5 stars3.00$33.88 141.1%10Short Interest ↓1.32%VIRVir Biotechnology$10.11+0.6%4.1875 of 5 stars2.83$34.83 244.5%6Analyst Revision1.31%MRVIMaravai LifeSciences$4.77+4.4%4.5776 of 5 stars2.36$10.28 115.5%111.23%PSTXPoseida Therapeutics$9.503.6948 of 5 stars2.00$9.50 0.0%50.95%PACBPacific Biosciences of California$1.64+2.5%1.9363 of 5 stars2.50$2.95 80.2%12Gap Up0.76%VERVVerve Therapeutics$6.14+0.7%2.752 of 5 stars3.00$25.75 319.4%40.74%FLGTFulgent Genetics$17.10-2.3%4.1689 of 5 stars2.00$22.00 28.7%1Positive News0.71%RGNXREGENXBIO$7.37+3.1%4.3506 of 5 stars2.92$35.27 378.6%12Analyst Forecast0.62%ALLOAllogene Therapeutics$1.82-1.1%2.6609 of 5 stars2.90$9.73 434.8%10Positive News0.46%SGMOSangamo Therapeutics$1.09-0.9%2.7783 of 5 stars2.67$5.50 404.6%6Gap Down0.41%SANASana Biotechnology$3.16-2.8%3.0376 of 5 stars2.80$14.25 350.9%5Gap Down0.29%TSVT2seventy bio$2.61+7.0%2.5785 of 5 stars2.56$9.00 244.8%9Positive News0.28%CRBUCaribou Biosciences$1.53-0.6%2.6294 of 5 stars3.00$10.33 575.4%5Gap Up0.22%EDITEditas Medicine$1.22-1.6%4.5126 of 5 stars2.07$7.00 473.8%14Short Interest ↑News Coverage0.18%LYELLyell Immunopharma$0.58+3.0%2.2563 of 5 stars1.50$1.00 73.8%20.01%SCLXScilex$0.45-4.3%3.7303 of 5 stars3.00$11.33 2,424.1%3Earnings ReportNews Coverage This page (NASDAQ:GNOM) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNOM Stock Alerts